DOI: 10.1055/s-00000054

Pharmacopsychiatry

Issue 04 · Volume 44 · June 2011 DOI: 10.1055/s-002-22100

Original Paper

  • 123
    Ghio, L.; Natta, W.; Barbato, A.; Marcenaro, M.; Gotelli, S.; Jones, P. B.; Parabiaghi, A.:

    Schizophrenia Trial Participation: Perceived Inclusion Barriers and Beliefs about Antipsychotics

  • 129
  • 135
    Xiang, Y.-T.; Wang, C.-Y.; Ungvari, G. S.; Kreyenbuhl, J. A.; Chiu, H. F. K.; Lai, K. Y. C.; Lee, E. H. M.; Bo, Q.-J.; Dixon, L. B.:

    Weight Changes and their Associations with Demographic and Clinical Characteristics in Risperidone Maintenance Treatment for Schizophrenia

  • 142
    Molina, J. D.; Toledo-Romero, F.; López-Rodríguez, E.; Amorin-Díaz, M.; Lerma-Carrillo, I.; López-Muñoz, F.:

    Augmentation Treatment with Amisulpride in Schizophrenic Patients Partially Responsive to Olanzapine

  • 148
    Szulc, A.; Galinska, B.; Tarasow, E.; Waszkiewicz, N.; Konarzewska, B.; Poplawska, R.; Bibulowicz, D.; Simonienko, K.; Walecki, J.:

    Proton Magnetic Resonance Spectroscopy Study of Brain Metabolite Changes after Antipsychotic Treatment

  • Letter

  • 158
    Sánchez-Romero, A.; Mayordomo-Aranda, A.; García-Delgado, R.; Durán-Quintana, J. A.:

    Probable Interaction between Trazodone and Carbamazepine

  • 159
    Bachmann, H. S.; Lieb, B.; Bonnet, U.; Specka, M.; Augener, S.; Siffert, W.; Scherbaum, N.:

    Influence of the 393T>C Polymorphism of the GNAS1 Gene on the Intensity of Opiate Withdrawal

  • 161
    Eckert, G. P.; Schaeffer, E. L.; Schmitt, A.; Maras, A.; Gattaz, W. F.:

    Increased Brain Membrane Fluidity in Schizophrenia

  • Erratum

  • 163